Glass House Brands (GLAS) Other Working Capital Changes (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Other Working Capital Changes of $3.0 million for Q1 2026, up 4.55% year-over-year from $2.9 million in Q1 2025, and up 129.63% quarter-over-quarter from -$10.2 million in Q4 2025.
Glass House Brands (GLAS) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Other Working Capital Changes for 7 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 4.55% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at -$1.2 million (down 106.7% YoY), while the FY2025 annual figure was -$1.3 million, down 108.59% from the prior year.
- Other Working Capital Changes advanced to $3.0 million in Q1 2026 per GLAS's latest filing, from -$10.2 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.7 million in Q4 2024 and bottomed at -$3.8 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged $260745.2 across 5 years, with a median of $6000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes surged 14379.1% — and 2025, when it slumped 1609.59%.
- Glass House Brands' Other Working Capital Changes stood at $11.9 million in 2022, then sank by 90.51% to $1.1 million in 2023, then sank by 39.94% to $678000.0 in 2024, then plunged by 1609.59% to -$10.2 million in 2025, then surged by 129.63% to $3.0 million in 2026.
- Business Quant data shows GLAS's Other Working Capital Changes at $3.0 million in Q1 2026, -$10.2 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Glass House Brands | 837.25 Mn | 818.69 Mn | 15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,000.00 |
| Mar 31, 2026 | -14,000.00 |
| Mar 31, 2026 | -14,000.00 |
| Dec 31, 2025 | -1.05 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | -96,000.00 |
| Jun 30, 2025 | -96,000.00 |
| Jun 30, 2025 | -96,000.00 |
| Mar 31, 2025 | 2.06 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 3.73 Mn |
| Dec 31, 2024 | 3.73 Mn |
| Dec 31, 2024 | 3.73 Mn |
| Sep 30, 2024 | -3,000.00 |
| Sep 30, 2024 | -3,000.00 |